Somnomed Ltd
F:RJV

Watchlist Manager
Somnomed Ltd Logo
Somnomed Ltd
F:RJV
Watchlist
Price: 0.422 EUR -4.09% Market Closed
Market Cap: 91.2m EUR

Net Margin
Somnomed Ltd

-3.1%
Current
-8%
Average
1.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-3.1%
=
Net Income
-3.5m
/
Revenue
111.5m

Net Margin Across Competitors

No Stocks Found

Somnomed Ltd
Glance View

Market Cap
91.2m EUR
Industry
Health Care

SomnoMed Ltd. produces and sells oral treatment of sleep related disorder devices. The company is headquartered in Sydney, New South Wales. The company went IPO on 2004-08-27. The firm provides treatment solutions for sleep-related breathing disorders, including obstructive sleep apnea, snoring, and bruxism. SomnoMed has developed the SomnoDent, a collection of oral devices. SomnoDent includes two product line, such as signature line and standard line. Its signature line products include Herbst Advance Elite, Fusion, Flex and Classic, and standard line products include Herbst Advance, Air/Air+, Morning Repositioner and Alpha. SomnoMed has developed the SomnoBrux, a custom fit acrylic occlusal splint. SomnoBrux product includes Michigan. SomnoMed has developed the SomGauge, is an autoclavable instrument, which can be used to construct accurate and reliable bite records.

RJV Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-3.1%
=
Net Income
-3.5m
/
Revenue
111.5m
What is the Net Margin of Somnomed Ltd?

Based on Somnomed Ltd's most recent financial statements, the company has Net Margin of -3.1%.

Back to Top